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Tandem Mannich/Diels–Alder reactions for the
synthesis of indole compound libraries†
Peng Wu,‡a Michael A˚xman Petersen,‡a Rico Petersen,a Thomas Flagstad,a
Rachel Guilleux,b Martin Ohsten,b Re´my Morgentin,b Thomas E. Nielsen*ac
and Mads H. Clausen*ad
A tandem Mannich/Diels–Alder sequence for the synthesis of small-
molecule libraries with an indolyl-octahydro-3a,6-epoxy-isoindole
core structure is demonstrated in this study. Representative diversiﬁ-
cation examples based on this scaﬀold were performed, and a library is
being produced within the European Lead Factory (ELF) Consortium.
A large portion of pharmaceutically active compounds and
approved drugs,1 including all small-molecule kinase inhibitors
approved by the FDA so far,2,3 are structurally dependent on
heterocyclic scaﬀolds.4 The indole core structure is embedded
in a plethora of compounds, which exhibit a broad range of
biological activities, such as anticancer,5 antibacterial,6 anti-
inammatory,7 and anti-HIV,8 and is clearly one of the most
intensively studied heterocyclic scaﬀolds.9 In fact, indole or
fused indole moieties are present in more than 50 FDA-
approved small-molecule drugs and countless biologically
active compounds currently in clinical or preclinical develop-
ment.1 Due to the fact that present drug discovery eﬀorts tend to
focus on a limited number of scaﬀolds, there is a growing
interest within the chemical and pharmaceutical communities
to develop synthetic approaches towards small-molecule
libraries that also incorporate new scaﬀolds.10 Properties
relating to lipophilicity, fraction of sp3-hybridised carbon
atoms, ratio of chiral/non-chiral centers, and drug-likeness
parameters diﬀerentiate these newly sought-aer scaﬀolds
from most traditional aromatic scaﬀolds. It is expected that the
exploitation of new chemical space represented by these new
scaﬀolds will be associated with novel physico-chemical prop-
erties and potentially useful biological eﬀects.11
The synthesis of biologically active and structurally diverse
small molecule libraries is a current focus of our group.12–14 As
a continuation of our eﬀorts to synthesize indole derivatives,15
the amine protected compounds 1 with an indolyl-hexa-
hydroepoxyisoindole core was designed. This scaﬀold has
previously been synthesized employing an intramolecular
Diels–Alder reaction16–18 and is virtually unexplored biologically.
We envisioned its formation through a convenient tandem
Mannich/Diels–Alder reaction sequence. Subsequent cycles of
deprotection and functionalization lead to indole compounds 3
with an octahydro-3a,6-epoxyisoindole core and three sites for
diversication: one introduced intrinsically by the indole
component, in addition to a primary amine and a secondary
amine for further decoration (Fig. 1). In the present work, we
describe the synthesis of a small-molecule library based on this
indolyl-octahydroepoxyisoindole scaﬀold (3), which combines
a bicyclic aromatic indole with a tricyclic aliphatic 3a,6-epoxy-
Fig. 1 Production of indole compounds 3 through cycles of depro-
tection and functionalization.
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isoindole ring, the latter displaying a high Fsp3 value and
several chiral centers.
The synthesis of substrate 4 for the Mannich/Diels–Alder
reaction was achieved by protection of furfurylamine 5, followed
by formylation using phosphoryl chloride in DMF to give alde-
hyde 8,19 which readily reacted with allylamine to aﬀord the
Schiﬀ base 4 in high yield (Fig. 2).
In initial experiments with the one-pot Mannich/Diels–Alder
reaction sequence, indole was employed as the C-nucleophile in
THF at 70 C, together with CBzCl, to give the amino-protected
compound 1b in 56% yield (entry 1, Table 1). This process is
easily applicable to other indole nucleophiles, substituted with
either electron-withdrawing or electron-donating groups,
aﬀording the corresponding tricyclic 3a,6-epoxyisoindole
derivatives 1a and 1c–e in good yields ranging from 59 to
72% (Table 1, entries 1 and 3–6). Attempts to use other
C-nucleophilic aromatic systems, such as 1,3-dimethox-
ybenzene, 1H-pyrrolo[2,3-b]pyridine, 1H-indazole, and thio-
phene, in this one-pot process led to intractable mixtures with
little or no trace of Diels–Alder product (Table 1, entries 6–9).
The reaction was monitored by LC-MS, where Mannich inter-
mediates 9a–e could be observed, as detected by a signicant [M
+ Na+] peak, while the Diels–Alder products 1a–e were charac-
terized by a signicant [M + H+] peak. The relative stereo-
chemistry was determined by NOESY analysis. Although
compounds 1 were obtained as racemates, it is noteworthy to
mention the possibility of accessing both enantiomers, through
either chiral preparative HPLC or enantioselective Diels–Alder
reactions,20,21 during lead optimization of identied hits.
Removal of the phthalimido protecting group of 1a–e with
hydrazine and hydrochloric acid in methanol aﬀorded the cor-
responding compounds with a primary amine handle, which was
subjected to a subsequent round of diversication steps.§
Selected modication examples include sulfonylation with 4-
(triuoromethyl)benzene sulfonyl chloride to give 2a, TBTU-
mediated acylation with cyclopropanecarboxylic acid to give 2b,
urea-formation using phenyl isocyanate to give 2c, and acylation
with cyclohexanecarbonyl chloride to give 2d (Fig. 3).
Cbz-deprotection of 2a–d was carried out under reducing
condition using 10% Pd/C and a hydrogen atmosphere.
However, except in the case of N-methyl indole substituted
compound 2a, epimerization at the 3-CH-indole position with
varied ratio ranging from 9 : 1 to 3 : 2 was observed during the
deprotection for compounds 2b–d. The crude compound was
simply isolated by concentration in vacuo and used directly in
the next steps, since any attempts to purify it by column chro-
matography failed probably due to poor stability of the free
amines.{
The secondary amino handle was then subject to another
round of diversication steps. For example, the deprotected
Fig. 2 Synthesis of substrate 4 for the Mannich/Diels–Alder reaction.
Table 1 One-pot Mannich/Diels–Alder reaction
Entry Nucleophilea Product 1 Yieldb
1 N-Methylindole 1a 59%
2 Indole 1b 56%
3 6-Fluoroindole 1c 62%
4 5-Methoxy-indole 1d 72%
5 5-Fluoroindole 1e 60%
6 1,3-Dimethoxybenzene 1f —c
7 1H-Pyrrolo[2,3-b]pyridine 1g —c
8 1H-Indazole 1h —c
9 Thiophene 1i —c
a 4 equiv. of nucleophile was added in the reaction. b Isolated yield aer
column chromatography. c Intractable mixture.
Fig. 3 Examples of functionalized compounds 2 after the ﬁrst step. *
Deprotection condition: hydrazine, 2 M HCl (aq.), MeOH, 21 C, 1 h.





























































































product of sulfonamide 2a was converted to the bissulfonamide
3a, alkylated compound 3b, and urea 3c. The deprotected
product of amide 2b was functionalized to give sulfonylated
compound 3d and acylated compound 3e through a sulfonyla-
tion reaction and a TBTU-coupling reaction, respectively, and
the free amine derived from urea compound 2c was further
functionalized to give sulfonylated compound 3f and amide 3g
(Fig. 4).
All of the functionalized compounds 3a–g were puried by
direct preparative HPLC, which underpin the subsequent
production of a screening compound library. Based on the steps
of phthalimido deprotection, functionalization of primary
amine, Cbz deprotection, and functionalization of the
secondary amine for the synthesis of compounds with an
indolyl-octahydroepoxyisoindole core, a collection of 120
compounds that resemble the structural features of compounds
3a–c have been produced as a part of a small-molecule
screening library under the ELF consortium. All produced
compounds and most of the enumerated compounds are
compliant with Lipinski's Rule of Five in terms of clog P values
and MW (Fig. 5).
Eﬀectively, the production focused on nal compounds in
N-methyl indole series since no epimerization at the 3-CH-
indole position occurred during the Cbz-deprotection step.
Noteworthy, the Mannich/Diels–Alder reaction was
reproducible on a 0.1 mol scale with yields comparable to those
shown in Table 1. To expand the library, future productions will
involve additional N-substituted indoles. A systematic relative
conguration assignment method could also be approached
with the aim to include both diastereomers from N-unsub-
stituted indoles series in the library, since most of these dia-
stereomers could be separated by preparative LCMS (C18-
Fig. 4 Examples of validated compounds for library synthesis. * Deprotection condition: 10% Pd/C (10 mol%), H2, MeOH, DMF, 21 C, overnight.
Fig. 5 Physical chemical property analysis of the produced
compounds (red dots) vs. enumerated compounds in library (blue
dots).





























































































phase). The goal is to access new, biologically relevant chemical
scaﬀolds that are not represented in existing screening
collections.
Conclusions
An eﬃcient protocol for the rapid assembly of indolyl-hexahy-
dro-3a,6-epoxyisoindole via a tandem Mannich/Diels–Alder
synthesis sequence has been developed in the reported study.
Diversication of the indolyl-octahydroepoxyisoindole core
through amino group functionalization has led to the validation
of 120 compounds which will be incorporated in a small-
molecule library under the ELF consortium.
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